Home » FDA Finds Data Falsification in CRO Cetero Studies
FDA Finds Data Falsification in CRO Cetero Studies
The FDA is notifying pharmaceutical companies that testing conducted by Cetero Research in support of marketing applications may need to be repeated after agency investigations called five years of data into question.
Clinical Trials Advisor
Clinical Trials Advisor
Upcoming Events
-
07May
-
14May
-
30May